Allergan Launches Juvéderm® VOLITE - An Innovative Injectable Treatment Designed to Improve Skin Quality for up to 9 Months

DUBLIN, January 27, 2017 /PRNewswire/ --





-- Allergan enters skin quality category with new injectable product using VYCROSS(R)

technology[1] for use on the face, neck, décolletage and hands[2]

--  Hyaluronic Acid (HA) gel designed to improve skin's smoothness (absence of fine

lines), hydration and elasticity for up to nine months with just one treatment[3]

-- Global research shows more than half of women say appearance of skin contributes to

their outer beauty[4]

Allergan plc , a leading global pharmaceutical company, announced today its entry into the skin quality category with the launch of Juvéderm(R) VOLITE.[2] This is Allergan's first injectable product specifically designed to improve skin quality[5] and last up to nine months with just one treatment session.[3] This innovative new Allergan product uses the unique patented VYCROSS(R) technology.[1]

A new innovation for skin quality 

The new HA injectable treatment delivers improvements in skin smoothness (absence of fine lines), hydration and elasticity,[2] and is designed to last for up to nine months with just one treatment.[3] Clinical data so far has shown significant improvements in skin quality for up to 6 months, and the clinical study is ongoing.[6],[7] Juvéderm(R) VOLITE aims to deliver results that last and eliminate the need for multiple treatments.[3] It should be injected intradermally and can be used to treat the face, neck, décolletage and hands and contains the anaesthetic lidocaine, to enhance patient comfort.[2]

Dr Patricia Ogilvie, Leading Dermatologist, Germany, says: "Juvéderm(R) VOLITE answers a real need for a treatment that delivers a healthy-looking glow. Combined with the fact that only one treatment is needed to achieve results, this product will be a game changer in my clinic. I believe that great skin can have a profound impact on patients' everyday lives - in particular their confidence. It goes far beyond aesthetics - when a patient is happy with how they look on the outside, this affects how they feel on the inside. Juvéderm(R) VOLITE is a genuinely innovative treatment option that I'm excited to be able to offer my patients."

For more information and to read the rest of this press release please go to: http://www.allergan.com/news/news/allergan-launches-juvederm-volite


 
Contact: 
Janet Kettels, +44-7738-506-476 
Karen Dennehy, +44-7824-017-950

 



 


Allergan plc

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234